At a glance
ClinicalIndex Comparison RecordN/ACompleted· 158 enrolled
Drug / intervention
Active MeRT Treatment +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Double Blind, Randomized, Sham-Controlled, Clinical Trial to Evaluate The Safety And Efficacy Of Biometrics-Guided Magnetic EEG Resonance Therapy (MeRT) Treatment Of Post-Traumatic Stress Disorder
In Brief
A clinical study evaluating Active MeRT Treatment and Sham MeRT Treatment for PostTraumatic Stress Disorder and 2 related conditions. Completed, enrolled 158 participants across 8 sites.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of individualized, Biometrics-guided Magnetic e-Resonance Therapy (MeRT) treatment of Post-Traumatic Stress Disorder
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedDec 2016
Enrollment StartApr 2022
Primary CompletionSep 2025
Study CompletionNov 2025
TodayJul 2026
First PostedDec 13, 2016
Enrollment StartApr 4, 2022
Primary CompletionSep 18, 2025
Study CompletionNov 4, 2025
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 9.6 years ago
Interventions
Active MeRT Treatmentdevice
A personalized biometrics-guided protocol known as magnetic EEG/ECG resonance therapy (MeRT) treatment that is tailored specifically to each participant's EEG intrinsic alpha frequency (IAF). rTMS is applied at the participant's IAF.
Sham MeRT Treatmentdevice
rTMS coil does not emit magnetic stimulation.